Kanako Kita, Yasutomo Imai, Makoto Nagai, Masaru Natsuaki, & Nobuo Kanazawa. (2023). Dupilumab treatment reduces serum SCCA2 levels in patients with atopic dermatitis. Frontiers Media S.A..
Chicago Style (17th ed.) CitationKanako Kita, Yasutomo Imai, Makoto Nagai, Masaru Natsuaki, and Nobuo Kanazawa. Dupilumab Treatment Reduces Serum SCCA2 Levels in Patients with Atopic Dermatitis. Frontiers Media S.A., 2023.
MLA (9th ed.) CitationKanako Kita, et al. Dupilumab Treatment Reduces Serum SCCA2 Levels in Patients with Atopic Dermatitis. Frontiers Media S.A., 2023.
Warning: These citations may not always be 100% accurate.